In this episode of Expert Answers join Christian Schnell, Associate Director of Oncology at Novartis in Basel, as he answers questions from a recent webinar on accurate PK-PD assessment and corresponding antitumor activity in pharmacology studies for oncology research.

For more information, to watch the webinar, or to download a copy of the full Q&A Report, click here.